Nanotech Investing Longeveron® Announces Third Quarter 2025 Financial Results and Provides Business Update
Nanotech Investing Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
Nanotech Investing Longeveron® Co-Founder and Chief Science Officer Dr. Joshua Hare Interviewed on NPR's BioTech Nation Discussing Potential Breakthrough Stem Cell Therapy for Hypoplastic Left Heart Syndrome , a Rare Pediatric Congenital Heart Defect
Nanotech Investing Longeveron® to Participate in the 4th Annual ROTH Healthcare Opportunities Conference
Nanotech Investing George Paletta, Jr., MD, MBA, Internationally Acclaimed Entrepreneur, Investor and Surgeon, Elected to Longeveron® Board of Directors
Nanotech Investing Longeveron® to Attend Alliance for Regenerative Medicine's Cell & Gene Meeting on the Mesa
Nanotech Investing Longeveron® to Present at the H.C. Wainwright 27th Annual Global Investment Conference
